SCHEMBL7898009

SCHEMBL7898009

COc1cccc(Cc2ccc3c(c2)CCC3NS(=O)(=O)C(C)C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA2 P42262 1/20 0.48
KCNA5 P22460 2/20 0.43
PDE4A P27815 3/20 0.41
PDE4B Q07343 3/20 0.41
PDE4C Q08493 3/20 0.41
PDE4D Q08499 3/20 0.41
HCRTR1 O43613 1/20 0.40
HCRTR2 O43614 1/20 0.40
MAOB P27338 2/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CCR2 P41597 1/20 0.39
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
ALDH1A1 P00352 1/20 0.39
NPY5R Q15761 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
THRB P10828 1/20 0.38
PPARD Q03181 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7900252 0.86 GRIA2 (0.50) GRIA2PDE4APDE4BPDE4CPDE4D
SCHEMBL7900317 0.85 GRIA2 (0.49) GRIA2PDE4APDE4BPDE4CPDE4D
SCHEMBL7888226 0.84 GRIA2 (0.49) GRIA2PDE4APDE4BPDE4CPDE4D
SCHEMBL7890611 0.83 GRIA2 (0.48) GRIA2PDE4APDE4BPDE4CPDE4D
SCHEMBL28795623 0.83 GRIA2 (0.48) GRIA2KCNA5PDE4APDE4BPDE4C
SCHEMBL7896164 0.82 GRIA2 (0.49) GRIA2ALDH1A1LMNA
SCHEMBL7898805 0.82 GRIA2 (0.47) GRIA2CA1CA2HTR6
SCHEMBL7897516 0.82 GRIA2 (0.56) GRIA2MAOBCCR2
SCHEMBL7896403 0.81 GRIA2 (0.52) GRIA2PDE4APDE4BPDE4CPDE4D
SCHEMBL1591092 0.79 GRIA2 (0.62) GRIA2PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8633237-B2 Indane derivatives MERCK SHARP & DOHME B.V. (NL) 2014-01-21 US disclosed
US-8633237-B2 Indane derivatives MERCK SHARP & DOHME B.V. (NL) 2014-01-21 US disclosed
US-20120202781-A1 INDANE DERIVATIVES MSD OSS B.V. (NL) 2012-08-09 US disclosed
US-20120202781-A1 INDANE DERIVATIVES MSD OSS B.V. (NL) 2012-08-09 US disclosed
CN-102365265-A Indane derivatives ORGANON NV 2012-02-29 CN disclosed
WO-2010115952-A1 INDANE DERIVATIVES N.V. ORGANON (NL) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202781-A1 INDANE DERIVATIVES CHRNA5, CHRNA2, GRIK5 GRIA2 24/4885KCNA5 863/4885PDE4A 2027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.